Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study

AIDS Research and Therapy

Volumn 9, Issue , 2012, Pages

  Meybeck, Agnes ^a,b   Lecomte, Lydie ^a   Valette, Michel ^a   Van Grunderbeeck, Nicolas ^a   Boussekey, Nicolas ^a   Chiche, Arnaud ^a   Georges, Hugues ^a   Yazdanpanah, Yazdan ^a   Leroy, Olivier ^a  

^a Hôpital de Tourcoing   (France)

^b CENTRE HOSPITALIER DE TOURCOING   (France)

Author keywords

HAART; HIV; Intensive care

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL;

EID: 84866694548     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-9-27     Document Type: Article

References (27)

1. Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, Pellegrin JL, Katlama C, Dabis F, Leport C, . Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO8 APROCO-COPILOTE Study Group; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO3 AQUITAINE Study Group HIV-infected adults with CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Defic Syndr 2007, 46:72-77. Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO8 APROCO-COPILOTE Study Group; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO3 AQUITAINE Study Group.
2. Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004, 18:1429-1433. 10.1097/01.aids.0000131301.55204.a7, 15199319.
3. Palacios R, Hidalgo A, Reina C, de la Torre MV, Marquez M, Santos J. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Medicine 2006, 7:193-196. 10.1111/j.1468-1293.2006.00353.x, 16494634.
4. Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ. Intensive care in patients with HIV infection in the era of higly active antiretroviral therapy. Chest 2004, 125:1800-1804. 10.1378/chest.125.5.1800, 15136393.
5. Vargas-Infante YA, Lourdes Guerrero M, Ruiz-Palacios GM, Sot-Ramirez LE, Del Rio C, Carranza J, Dominguez-Cherit G, Sierra-Madero JG. Improving outcome of human immunodeficiency virus-infected patients in a mexican intensive care unit. Arch Med Res 2007, 38:827-833. 10.1016/j.arcmed.2007.05.007, 17923262.
6. Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretrovial therapy. Am J Respir Crit Care Med 2002, 166:262-267. 10.1164/rccm.2111025, 12153955.
7. Powell K, Lucian Davis J, Morris AM, Chi A, Bensley MR, Huang L. Survival for patients with human immunodeficiency virus admitted to the intensive care unit continues to improve in the current era of highly active antiretroviral therapy. Chest 2009, 135:11-17. 10.1378/chest.08-0980, 2742310, 18719058.
8. Davis JL, Morris A, Kallet RH, Powell K, Chi AS, Bensley M, Luce JM, Huang L. Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax 2008, 63:988-993. 10.1136/thx.2008.095786, 2677080, 18535118.
9. Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM, Soto-Ramirez LE, Carranza J, Dominguez-Cherit G, Sierra-Madero JG. Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res 2007, 38:827-833. 10.1016/j.arcmed.2007.05.007, 17923262.
10. Croda J, Garcia Croda M, Neves A, De Sousa dos Santos S. Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009, 37:1605-1611. 10.1097/CCM.0b013e31819da8c7, 19325488.
11. Huang L, Quartin A, Jones D, Havlir DV. Intensive care of patients with HIV infection. N Engl J Med 2006, 355:173-181. 10.1056/NEJMra050836, 16837681.
12. From the Center for Disease Control and prevention 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993, 269:729-730. From the Center for Disease Control and prevention.
13. McCabe WR, Jackson CG. Gram-negative bacteremia: etiology and ecology. Arch Intern Med 1962, 110:847-855.
14. Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. 10.1001/jama.1993.03510240069035, 8254858.
15. Teasdale G, Murray G, Parker L, Jennett B. Adding up the Glasgow Coma Score. Acta Neurochir 1979, 28(Suppl):13-16.
16. Watcher RM, Luce JM, Hopewell PC. Critical care of patients with AIDS. JAMA 1992, 267:541-547. 10.1001/jama.1992.03480040089037, 1729577.
17. Khouli H, Afrasiabi A, Shibli M, Hajal R, Barrett CR, Homel P. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005, 20:327-333.
18. Casalino E, Mendoza-Sassi G, Wolff M, Bedos JP, Gaudebout C, Regnier B, Vachon F. Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest 1998, 113:421-429. 10.1378/chest.113.2.421, 9498962.
19. Nickas G, Watcher RM. Outcomes of intensive care of patients with human immunodeficiency virus infection. Arch Intern Med 2000, 160:541-547. 10.1001/archinte.160.4.541, 10695695.
20. Afessa B, Green B. Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU: the PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 2000, 118:138-145. 10.1378/chest.118.1.138, 10893371.
21. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
22. The Acute Respiratory Distress Syndrome Network Ventilation with lower tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000, 342:1301-1308. The Acute Respiratory Distress Syndrome Network.
23. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early Goal-Directed Therapy Collaborative Group: Goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307, 11794169.
24. Morris A, Watcher RM, Luce J, Turner J, Huang L. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS 2003, 17:73-80. 10.1097/00002030-200301030-00010, 12478071.
25. Zolopa AR, Andersen J, Komarow L, Sanne I, Sanchez A, Hogg E, Sckow C, Powderly W, . For the ACTG A5164 study team Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009, 4:e5575. 10.1371/journal.pone.0005575, 2680972, 19440326, For the ACTG A5164 study team.
26. Makadzange AT, Ndhlovu CE, Takarinda K, Reid M, Kurangwa M, Gona P, Hakim JG. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in Sub-Saharan Africa. Clinical Infect Dis 2010, 50:1532-1538.
27. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T, Nair G, Bamber S, Singh A, Khan M, Pienaar J, El-Sadr W, Friedland G, Abdool Karim Q. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010, 362:697-706. 10.1056/NEJMoa0905848, 3076221, 20181971.